Gan & Lee Pharma Surges as NMPA Fast‑Tracks Cell & Gene Therapies in China
Gan & Lee Pharmaceuticals soars after NMPA’s new cell‑gene therapy review plan—find out how the 30‑day pathway fuels investor optimism.
3 minutes to read
GAN & LEE PHARMACEUTICALS